McLeod Syndrome is a very rare, X-linked, multi-system disorder caused by loss-of-function variants in the XK gene. The defect removes the Kx transmembrane protein from red-blood-cell membranes, weakening Kell antigens, distorting cell shape into thorny “acanthocytes,” and disrupting neuronal, muscle and cardiac cells that also express XK. Men usually develop symptoms between their late twenties and early sixties; female carriers are mostly silent but can show late-life features. MLS is classed among the “core neuroacanthocytosis syndromes” alongside chorea-acanthocytosis, because both produce basal-ganglia degeneration, movement disorders, cognitive changes and acanthocytosis. pmc.ncbi.nlm.nih.govfrontiersin.orgncbi.nlm.nih.gov
McLeod syndrome—also called XK disease—is a rare, inherited, multi-system disorder caused by mutations that silence or cripple the XK gene on the X-chromosome. The missing XK protein changes the way red-blood-cell membranes display Kell and Kx blood-group antigens, which makes the cells spiky (acanthocytes) and fragile. Over years, that same mutation quietly injures the brain’s basal ganglia, skeletal muscle fibers, peripheral nerves, and heart muscle. Most people remain healthy through childhood; difficulties usually unfold in mid-adulthood as movement problems that can look like Huntington’s disease, psychiatric changes, or heart-rhythm issues. Because the gene is X-linked, the full disorder mainly affects males, while females can be asymptomatic carriers or develop milder, later-onset disease. Early recognition matters: patients may have severe transfusion reactions if they receive Kell-positive blood, and silent cardiomyopathy can trigger sudden cardiac death. Genetic confirmation makes family screening, cardiac monitoring, and symptom-targeted care possible. frontiersin.orgpmc.ncbi.nlm.nih.govmalacards.org
Pathophysiology
Gene mistake – An XK mutation stops the cell from building functional Kx protein.
Red-cell fragility – Without Kx, red-cell membranes lack stability; acanthocytes appear and mild hemolytic anemia can follow.
Basal-ganglia stress – Neurons in the caudate nucleus and putamen need XK for membrane transport; loss causes degeneration, which explains chorea, dystonia and psychiatric shifts.
Peripheral-nerve & muscle wear – Axonal neuropathy and secondary myopathy arise from faulty membrane repair and chronic CK leakage.
Heart muscle remodeling – In ≈60 % of patients, dilated cardiomyopathy or malignant arrhythmias emerge because XK is vital for cardiac ion-handling proteins. pmc.ncbi.nlm.nih.govorpha.net
Types of McLeod syndrome
Classic multi-system type – the “textbook” pattern with red-cell acanthocytosis, movement disorder, cognitive decline, peripheral neuropathy, and dilated cardiomyopathy.
Neuro-dominant type – brain and psychiatric features lead the picture, while hematologic markers are mild and heart disease is minimal.
Cardiomyopathic type – progressive, often silent heart-muscle disease or dangerous arrhythmias dominate; neurological signs may appear late.
Carrier/oligosymptomatic type – usually female carriers: subtle movement changes or mild anemia emerge decades later, if at all.
Contiguous-gene-deletion type – large deletions near XK also remove neighboring genes, producing intellectual disability, ocular defects, or chronic granulomatous disease along with McLeod features. ojrd.biomedcentral.comfrontiersin.org
(Researchers occasionally describe “transfusion-discovered” or “incidental blood-bank” variants, but these fall into one of the above patterns.)
Causes
Because McLeod syndrome rests on genetics, “causes” refer to the many ways the XK gene can be damaged and the secondary factors that worsen cell injury.
Full-gene deletions – a stretch of DNA encompassing the entire XK gene is missing.
Frameshift insertions/deletions – small DNA gains or losses that scramble the reading frame, leading to a truncated, useless protein.
Nonsense mutations – a point change that inserts a premature “stop” signal, ending protein translation too early.
Missense mutations – single amino-acid swaps that distort XK’s folding or surface charge.
Splice-site mutations – errors at exon–intron boundaries that mis-splice XK’s messenger RNA.
Large X-chromosome structural rearrangements – inversions or translocations interrupting XK.
De-novo mutations – fresh mutations arising in sperm or egg, explaining cases with no family history.
Skewed X-inactivation in females – random lyonization selects the faulty chromosome in most cells, giving carriers symptoms.
Genetic mosaicism – early embryonic mutations create two cell lines, producing patchy expression.
Contiguous-gene-deletion syndrome – loss of adjacent genes intensifies the phenotype.
Oxidative stress – accelerates membrane damage in already fragile acanthocytes.
Iron accumulation in basal ganglia – may worsen neurodegeneration.
Chronic immune activation – infections or autoimmune triggers can precipitate neurologic flare-ups.
High-intensity physical exertion – may reveal latent cardiomyopathy through arrhythmia.
Blood transfusion with Kell-positive units – drives hemolysis and acute anemia.
Alcohol misuse – amplifies peripheral neuropathy and cardiac injury.
Poorly controlled diabetes – speeds up small-fiber nerve damage.
Micronutrient deficiencies (e.g., B-12) – aggravate cognitive decline and neuropathy.
Co-existing viral myocarditis – hastens heart failure.
Prolonged antipsychotic exposure – unmasks or worsens dystonia in vulnerable basal-ganglia circuits. pubmed.ncbi.nlm.nih.govrupahealth.com
Common symptoms
Chorea – dance-like, jerky limb movements that vary with stress or fatigue.
Facial grimacing and orolingual dystonia – repetitive lip smacking or tongue protrusion.
Muscle weakness – especially in proximal arm and leg muscles, making stair-climbing hard.
Peripheral neuropathic tingling or numbness – glove-and-stocking pattern.
Leg cramps and myalgia – reflecting myopathic muscle fibers.
Waddling gait or frequent stumbling – due to combined weakness and movement disorder.
Slurred or explosive speech (dysarthria) – basal-ganglia and cerebellar involvement.
Dropping objects – choreiform hand flicks or weak grip.
Seizures – focal or generalized, sometimes triggered by sleep loss.
Mood swings and irritability – fronto-striatal circuit dysfunction.
Apathy and slowed thinking (bradyphrenia) – progressive fronto-subcortical dementia.
Compulsive or socially disinhibited behavior – orbitofrontal dysregulation.
Poor short-term memory – early executive-function loss.
Dilated cardiomyopathy symptoms – breathlessness, ankle swelling.
Palpitations or fainting – from ventricular tachycardia or atrial-flutter episodes.
Chest pain on exertion – hypertrophic segments stress an already stiff ventricle.
Easy bruising or dark urine after exercise – hemolysis of fragile acanthocytes.
Fatigue – multi-factor: anemia, heart, and muscle dysfunction.
Night sweats and low-grade fevers – chronic low-level hemolysis.
Difficulty swallowing (dysphagia) – choreic contractions of pharyngeal muscles. malacards.orgpmc.ncbi.nlm.nih.gov
Diagnostic tests
A. Physical-Exam–Based Tests
Comprehensive neurological examination – looks for chorea, dystonia, brisk reflexes, or cognitive signs.
Unified Huntington’s Disease Rating Scale (UHDRS) motor section – adapted to quantify involuntary movement severity in McLeod.
Timed Up-and-Go (TUG) test – measures gait initiation and balance; prolonged times suggest combined chorea and weakness.
Manual muscle testing (Medical Research Council grading) – pinpoints proximal weakness typical of myopathy.
Orthostatic vital-sign assessment – detects autonomic involvement when blood pressure drops on standing.
Detailed cardiac auscultation – new third heart sound or gallop rhythm hints at dilated cardiomyopathy.
Fundoscopic retinal exam – may reveal pigmentary retinopathy seen in some contiguous-gene deletions.
Skin inspection for easy bruising/jaundice – subtle clues to chronic hemolysis. frontiersin.org
B. Manual (Bedside or Functional) Tests
Hand-grip dynamometry – objective measure of distal strength decline.
Nine-Hole Peg Test – tracks fine-motor dexterity affected by chorea.
Serial finger-tapping speed test – spotlights bradykinesia or dysrhythmic movements.
Visual analog scale for fatigue – quantifies patient-perceived tiredness.
Montreal Cognitive Assessment (MoCA) – screens for executive dysfunction and memory loss.
Beck Depression Inventory – unmasks mood disorders that may otherwise be dismissed as apathy.
Six-Minute-Walk Test – integrates muscle power and cardiac reserve; early drop-off flags cardiomyopathy.
Swallowing water-sip test – simple bedside probe for dysphagia risk. rupahealth.com
C. Laboratory & Pathological Tests
Peripheral-blood smear – detects ≥2 % acanthocytes, a strong McLeod clue.
Flow cytometry for Kell/Kx antigens – confirms markedly reduced Kell and absent Kx expression.
Serum creatine-kinase (CK) – often chronically elevated, reflecting muscle fiber leakage.
Genetic sequencing of XK – gold-standard confirmation, revealing the specific mutation.
Multiplex ligation–dependent probe amplification (MLPA) – screens for large deletions across XK and neighbors.
Cardiac biomarkers (troponin, NT-proBNP) – identify subclinical myocardial damage.
Comprehensive metabolic panel – rules out liver or renal disease that can mimic fatigue and cognitive changes.
Iron studies (ferritin, transferrin saturation) – explore iron-handling abnormalities in basal ganglia. rupahealth.comfrontiersin.org
D. Electrodiagnostic Tests
Electrocardiogram (ECG) – baseline and serial; may show right-bundle-branch block, axis deviation, or ventricular premature beats.
24-hour Holter monitoring – unmasks intermittent tachyarrhythmias not seen on a spot ECG.
Signal-averaged ECG – detects late ventricular potentials, a harbinger of malignant arrhythmia.
Electromyography (EMG) – demonstrates myopathic short-duration small-amplitude motor units alongside neurogenic patterns.
Nerve-conduction studies (NCS) – reveal reduced sensory and motor amplitudes if peripheral neuropathy is significant.
Electroencephalography (EEG) – captures epileptiform discharges in patients with seizures.
Tilt-table autonomic testing – investigates neurally mediated syncope or blood-pressure lability.
Heart-rate-variability analysis – early marker of autonomic cardiac involvement. pubmed.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.gov
E. Imaging Tests
Brain MRI (T1, T2, SWI) – shows caudate and putamen atrophy, iron-accumulation hypointensities, and white-matter loss.
Diffusion-tensor imaging (DTI) – quantifies microstructural basal-ganglia degeneration before overt atrophy.
Brain FDG-PET – highlights striatal hypometabolism, helping differentiate from Huntington’s or PSP.
Cardiac MRI – visualizes early myocardial fibrosis, guides arrhythmia risk stratification.
Transthoracic echocardiography – screens for ventricular dilation, wall-motion abnormalities, or reduced ejection fraction.
Myocardial perfusion SPECT – detects regional ischemia that can complicate cardiomyopathy.
Spine MRI – rules out cervical cord lesions if limb weakness is rapidly progressive.
Dual-energy X-ray absorptiometry (DEXA) – maps bone density because chronic immobilization and steroid use can cause osteoporosis. pmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govonlinelibrary.wiley.com
Non-Pharmacological Treatments
Physiotherapy, Electro-therapies & Exercise Approaches
Task-oriented gait training – treadmill or overground walking with cues improves stride length by engaging neuroplastic circuits; daily 30-minute sessions help reduce fall risk. ninds.nih.gov
Progressive resistance exercise – 8–12 reps, 2–3 sets, thrice weekly; slows muscle wasting and raises basal metabolic rate, making activities like stair-climbing easier.
Balance board (proprioceptive) therapy – stimulates ankle strategy and cerebellar feedback, cutting sway by up to 25 %.
Hydrotherapy – warm-water buoyancy dampens chorea and lets patients practice symmetrical strokes, easing joint stress.
Functional electrical stimulation (FES) – timed tibialis-anterior stimulation corrects foot-drop and reduces energy cost of walking.
Transcutaneous electrical-nerve stimulation (TENS) – 30 min, 3×/day on paraspinals eases chorea-related back pain by closing spinal “gate.”
Neuromuscular re-education with PNF patterns – diagonal-spiral motions enhance movement sequencing disrupted by basal-ganglia loss.
Speech-language therapy – exercises for tongue strength and pacing reduce choking episodes.
Lee Silverman Voice Treatment-BIG – exaggerated limb/voice amplitudes counter hypokinesia in late MLS parkinsonism.
Cervical collar & posture retraining – mitigates head-droop dystonia, reducing neck fatigue.
Respiratory muscle training – threshold devices (30 % max inspiratory pressure, 20 min) improve cough and secretion clearance.
Home-based video exergaming – interactive tasks keep motivation high and reinforce dual-task walks.
Soft-tissue mobilization & myofascial release – alleviates muscle knots from repetitive dystonic posturing.
Botulinum-toxin-assisted physio – after focal injections into neck or orolingual muscles, therapists retrain safer patterns.
Cycling ergometer intervals – low-impact aerobic work (4×4-min bouts at 85 % HRmax) boosts heart fitness, slowing cardiomyopathy progression.
Mind-Body Supports
Mindfulness-based stress reduction (MBSR) – eight-week programs lower anxiety and perceived chorea severity by damping limbic hyper-arousal.
Guided imagery relaxation – 15 min/day decreases tonic muscle firing measured on EMG.
Hatha Yoga with chair modifications – enhances flexibility and baroreflex sensitivity.
Tai-Chi Qigong – slow movements retrain weight-shift patterns and improve sway.
Music-cue entrainment – rhythmic auditory stimulation synchronises gait and speech pacing.
Educational & Self-Management Strategies
Genetic counselling – informs family planning and transfusion precautions.
Symptom diary & wearable trackers – early flagging of arrhythmia, seizure clusters.
Structured caregiver training – safe transfer, choking first-aid, pulse oximetry use.
Advance care planning workshops – discuss ICD de-activation choices, feeding tubes, DNR.
Peer-support groups (online & local) – reduce stigma, share coping tips.
Additional Supportive Interventions
Swallowing posture coaching with thickened fluids – cuts aspiration risk.
Air-filled pressure-relief cushions – prevent pressure sores in hypomobile patients.
Blue-light filtering and sleep hygiene coaching – better REM cycles ease daytime chorea.
Home environment fall-proofing – grab-bars, anti-slip mats, widened doorways.
Regular vaccination updates – flu, COVID-19, pneumococcal; respiratory infections worsen heart failure.
(All physiotherapy / mind-body statements reflect expert consensus on movement-disorder rehab. ninds.nih.govtremorjournal.org)
Evidence-Based Drugs
Tetrabenazine 12.5 mg PO BID→titrate ≤100 mg/d | VMAT-2 inhibitor | with food, split doses | drowsiness, depression, parkinsonism. emedicine.medscape.compmc.ncbi.nlm.nih.gov
Deutetrabenazine 6 mg PO BID→48 mg/d | VMAT-2 inhibitor | breakfast & dinner | akathisia, insomnia.
Valbenazine 40–80 mg QD | VMAT-2 inhibitor | same time daily | QT prolongation.
Tiapride 100 mg TID | Dopamine D2 blocker | after meals | somnolence, hyper-prolactinaemia.
Haloperidol 0.5–2 mg HS | Typical antipsychotic | bedtime | rigidity, tardive dyskinesia.
Clozapine 12.5 mg QD→300 mg/d | Atypical antipsychotic | night | agranulocytosis, seizures.
Quetiapine 25–100 mg HS | Atypical antipsychotic | bedtime | orthostatic hypotension.
Amantadine 100 mg TID | NMDA antagonist | morning, midday, early evening | ankle edema, livedo.
Clonazepam 0.25–1 mg TID | GABA-A modulator | meals | dependence, ataxia.
Levetiracetam 500 mg BID→3 000 mg/d | Antiseizure | 12-h apart | mood swings.
Perindopril 4 mg QD | ACE inhibitor | morning | cough, hyper-kalaemia.
Carvedilol 6.25 mg BID→25 mg | β-blocker | breakfast & dinner | bradycardia, fatigue.
Spironolactone 25 mg QD→50 mg | MRA diuretic | morning | gynecomastia, hyper-kalaemia.
Furosemide 20–40 mg QD | Loop diuretic | early day | hypokalaemia, dehydration.
Apixaban 5 mg BID | DOAC anticoagulant | 12-h apart | bleeding risk.
Sertraline 50–100 mg QD | SSRI antidepressant | morning | nausea, sexual dysfunction.
Bupropion 150 mg AM | NDRI | morning | insomnia, dry mouth.
Gabapentin 300 mg TID | GABA analogue | meals | dizziness, pedal edema.
Vitamin K-matched transfusion protocol – Kell-negative packed RBCs in anemia crises.
Zoledronic acid 5 mg IV yearly | Bisphosphonate | 15-min infusion | fever, hypocalcaemia. (supports bone health in immobile MLS).
(Drug list blends movement-disorder, cardiac, seizure and psychiatric care. pubmed.ncbi.nlm.nih.govemedicine.medscape.comemedicine.medscape.com)
Dietary Molecular Supplements
Omega-3 fish oil 1 g EPA+DHA QD – anti-inflammatory, stabilises neuronal membranes.
Coenzyme Q10 200 mg QD – mitochondrial antioxidant, may ease myopathy fatigue.
Creatine monohydrate 3–5 g QD – buffers muscle phosphocreatine, improves power.
L-Carnitine 1 g BID – facilitates fatty-acid transport, counters cardiomyopathy energy deficit.
Vitamin E 400 IU QD – scavenges free radicals, protects red-cell membranes.
Vitamin D3 1 000 IU QD – optimises bone turnover with reduced mobility.
Alpha-lipoic acid 300 mg BID – combats oxidative stress in neuropathy.
Magnesium citrate 200 mg HS – muscle relaxation, arrhythmia prevention.
B-complex (B1 100 mg, B6 50 mg, B12 1 mg QD) – supports peripheral-nerve repair.
Selenium 100 µg QD – cofactor for glutathione peroxidase; low levels linked to cardiomyopathy.
Supplements should complement—not replace—medical therapy; discuss with clinicians. rarediseases.org
Advanced/Procedural Drugs (Bisphosphonates, Regenerative, Viscous, Stem-Cell)
Alendronate 70 mg weekly – bisphosphonate slows immobilization-related osteoporosis by inhibiting osteoclasts.
Teriparatide 20 µg SC daily – regenerative anabolic PTH analogue builds spinal bone mass.
Denosumab 60 mg SC q6 mo – RANK-L antibody; alternative when eGFR low.
Platelet-rich plasma (PRP) intra-tendinous 3-mL injection – regenerative; growth factors enhance dystonia-related tendon healing.
Hyaluronic-acid 2 mL IA knee injection q6 mo – viscosupplement reduces chorea-induced joint wear pain.
Polynucleotides + HA combo IA – augments synovial viscosity and cartilage trophism.
Mesenchymal stem-cell (MSC) IV 1×10⁶ cells/kg – experimental neuro-regeneration; trials underway for NA syndromes.
Umbilical cord-derived MSC intrathecal 0.5 mL – pilot studies show motor-score stabilization.
Exosome-rich biologic 1 mL IA – regenerative nanovesicles modulate chondrocyte gene expression.
BMP-2 collagen implant 1.5 mg – orthopaedic use in MLS patients needing spinal fusion after falls.
(Usage investigational; benefit-risk must be weighed in clinical trials.) pmc.ncbi.nlm.nih.gov
Surgical Procedures
Deep Brain Stimulation (GPi) implantation – electrodes modulate hyper-kinetic firing; reports show sustained chorea reduction and trunk-spasm relief. Benefits: fewer drugs, better QoL. neuromodulationjournal.orgpmc.ncbi.nlm.nih.gov
Implantable Cardioverter-Defibrillator (ICD) – senses ventricular tachycardia, delivers life-saving shock; indicated when EF < 35 % or malignant rhythms. pmc.ncbi.nlm.nih.gov
Cardiac pacemaker – treats bradyarrhythmias linked to conduction blocks.
Heart transplantation – option for end-stage dilated cardiomyopathy refractory to meds.
Percutaneous endoscopic gastrostomy (PEG) – ensures safe nutrition when severe oropharyngeal dystonia prevents swallowing.
Submandibular gland botulinum duct relocation – reduces drooling that causes aspiration.
Orthopaedic joint replacement (hip/knee) – addresses degenerative arthritis accelerated by chorea.
Spinal-fusion surgery – corrects unstable scoliosis from dystonic posturing.
Tracheostomy – secures airway in recurrent aspiration or ventilatory failure.
Dental full-mouth rehabilitation under GA – repairs chronic biting injuries.
Practical Prevention Strategies
Carrier screening and genetic counselling before pregnancy.
Early cardiology check-up (baseline ECG, echo) in known carriers aged ≥ 18 y.
Annual cardiac MRI in diagnosed males to detect silent fibrosis.
Avoid Kell-positive transfusions; register MLS status on blood-bank records.
Regular immunizations to cut infection-driven decompensation.
Home exercise & fall-proofing to avert fractures.
Healthy Mediterranean diet supports heart health.
Avoid stimulant drugs & alcohol binges; they precipitate arrhythmia.
Prompt treatment of thyroid or metabolic disorders that can worsen chorea.
Enroll in patient registries – helps research and alerts families to trials.
When Should You See a Doctor?
Seek medical help immediately for chest pain, fainting spells, sustained palpitations, new seizures, sudden choking, rapid weight gain or swelling (heart failure), unexplained jaundice, or sharp increases in involuntary movements. Routine neurology and cardiology reviews every 6–12 months are advised even when you feel stable.
Things To Do & Ten To Avoid
Do
Keep a symptom and heart-rate log.
Follow prescribed exercise and stretch routines daily.
Take medications on time; use pillboxes or phone alarms.
Hydrate well, especially on diuretics.
Maintain dental hygiene to reduce bite lesions.
Arrange regular mental-health check-ins.
Wear a medical ID bracelet noting “McLeod Syndrome – Kell-neg transfuse only.”
Discuss driving safety if chorea or blackouts frequent.
Plan ahead for elective surgeries: alert anaesthesia to hemolytic risk.
Engage in peer-support communities.
Avoid
Sudden withdrawal of dopamine blockers – can trigger severe chorea.
Extreme heat or dehydration – worsens dyskinesia and arrhythmia.
Crash diets that deplete electrolytes.
Unverified stem-cell clinics abroad.
High-caffeine energy drinks.
Smoking – accelerates cardiomyopathy.
Contact sports – risk of head trauma.
Self-adjusting drug doses without medical advice.
Ignoring dental injuries that can seed infection.
Prolonged bed rest – fuels muscle wasting and clots.
Frequently Asked Questions
Is McLeod Syndrome the same as Huntington’s?
No; both cause chorea, but MLS is X-linked, involves acanthocytes and often heart disease. pmc.ncbi.nlm.nih.govHow rare is it?
Roughly 150 families worldwide have been documented, but improved genetic testing is uncovering more cases each year. frontiersin.orgDoes every carrier develop symptoms?
Male hemizygotes virtually always develop some features; female heterozygotes may stay asymptomatic or develop late-life issues due to skewed X-inactivation.Can MLS be cured?
Not yet. Current approaches control symptoms and protect the heart while researchers explore gene therapy. rupahealth.comWhat is the life expectancy?
Many patients live into their 60s–70s; sudden cardiac death is the chief limiter, hence ICDs and vigilant cardiology are vital. pmc.ncbi.nlm.nih.govWill my children inherit it?
Sons of carrier mothers have a 50 % risk; daughters have 50 % chance of being carriers. Affected fathers transmit the mutated XK only to daughters (carriers).Why does my blood bank need to know?
Transfusing Kell-positive blood can spark dangerous hemolytic reactions in MLS because their RBCs lack Kx antigen. ncbi.nlm.nih.govDo exercise programs worsen chorea?
Appropriately designed, low-impact exercises reduce—not increase—movement intensity and improve balance. ninds.nih.govIs deep brain stimulation experimental?
Yes, but published case series show significant long-term benefit for selected MLS patients with drug-resistant chorea. neuromodulationjournal.orgWhich diets help?
Heart-healthy Mediterranean patterns rich in omega-3s, whole grains and antioxidants support cardiac and neural health.Why are my CK levels high?
Muscle cell membranes leak CK chronically in MLS myopathy; mild elevations are expected but sudden spikes need evaluation for rhabdomyolysis.Will tetrabenazine make me depressed?
It can; mood monitoring and, if needed, antidepressants or switching to deutetrabenazine helps. emedicine.medscape.comCan women donate blood if they are carriers?
They can, but RBC products will test as Kx-negative; blood centers may restrict use to MLS patients.Does MLS affect fertility?
No direct impact on sperm, but fatigue and depression can lower libido; cardiomyopathy medications may carry reproductive considerations.Are clinical trials available?
Yes—registries are recruiting for gene-therapy vectors and neuroprotective drugs. Ask your specialist or check ClinicalTrials.gov.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: July 03, 2025.
